Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 17,465 | 17,429 | 37,599 | 54,731 | 50,306 |
| Cost of Goods | 9,978 | 14,337 | 20,777 | 15,230 | 18,797 |
| Gross Profit | 7,487 | 3,092 | 16,822 | 39,501 | 31,509 |
| Operating Expenses | 67,879 | 74,296 | 93,336 | 131,955 | 113,586 |
| Operating Income | -59,414 | -70,867 | -75,737 | -92,224 | -81,280 |
| Interest Expense | 12,422 | 12,265 | 12,089 | 10,363 | 9,746 |
| Other Income | 868 | 239 | 1,622 | 284,400 | 713 |
| Pre-tax Income | -70,968 | -82,893 | -86,204 | 181,813 | -90,313 |
| Income Tax | 28 | -110 | 163 | 11 | 46 |
| Net Income Continuous | -70,996 | -82,783 | -86,367 | 181,802 | -90,359 |
| Net Income Discontinuous | -31,674 | -40,073 | 96 | 619 | -2,105 |
| Minority Interests | N/A | 4 | -13 | -21 | -16 |
| Net Income | $-102,670 | $-122,860 | $-86,258 | $182,442 | $-92,448 |
| EPS Basic Total Ops | -1.44 | -1.74 | -1.23 | 2.62 | -1.34 |
| EPS Basic Continuous Ops | -1.00 | -1.17 | -1.23 | 2.61 | -1.31 |
| EPS Basic Discontinuous Ops | -0.44 | -0.57 | 0.00 | 0.01 | -0.03 |
| EPS Diluted Total Ops | -1.44 | -1.74 | -1.23 | 2.52 | -1.34 |
| EPS Diluted Continuous Ops | -1.00 | -1.17 | -1.23 | 2.51 | -1.31 |
| EPS Diluted Discontinuous Ops | -0.44 | -0.57 | 0.00 | 0.01 | -0.03 |
| EBITDA(a) | $-44,411 | $-55,552 | $-61,184 | $-78,511 | $-67,637 |